A PHASE II SINGLE-ARM INTERVENTION TRIAL OF NELFINAVIR IN PATIENTS WITH GRADE 2/3 or 3 CERVICAL INTRAEPITHELIAL NEOPLASIA
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Nelfinavir (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- 09 Nov 2020 Status changed from recruiting to withdrawn prior to enrolment (The study is going to open in a new site).
- 22 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2022.
- 22 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2022.